Loxof-OZ 10 Tablets

babies: not applicable. lactating mother: consult your doctor before using this medication during breastfeeding. pregnancy: levofloxacin and ornidazole is unsafe to use in pregnancy because it has harmful effects on the developing baby. consult your doctor. alcohol: it is not safe to drink alcohol while using levofloxacin, ornidazole. driving: levofloxacin and ornidazole tablets may cause dizziness.
do not drive if any symptoms alter your driving ability. kidney: the use of levofloxacin and ornidazole tablets is considered safe in patients with kidney disease. dose adjustment is not required.
consult your doctor. liver: levofloxacin and ornidazole tablets must be used with caution in patients with liver disease. dose adjustment is required.
consult your doctor..

Nausea Loss of appetite Dizziness Headache.

LOXOF OZ is a fluoroquinolone. it works by blocking the action of bacterial dna gyrase, which is required to synthesise bacterial dna.
hence, it stops the growth of bacteria. ornidazole is nitroimidazole.
it works by killing the parasites, and it damages the dna..

If you miss a dose, take LOXOF OZ as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• LOXOF OZ tablet is recommended by your doctor for diarrhoea and dysentery • drink plenty of fluids or water to prevent dehydration • consult your doctor if you find blood in stools • do not drive after taking this medication because it may cause dizziness or sleepiness • do not drink alcohol while taking this medication as it may cause excessive drowsiness • consult your doctor if you are experienced with tendons, numbness, or tingling sensation • tell your doctor if you are pregnant or breastfeeding • if diarrhoea persists for more than 24 hours, then consult your doctor immediately.

• levofloxacin + bepridil: concurrent use may result in an increased risk of qt-interval prolongation • levofloxacin + pimozide: concurrent use may result in an increased risk of qt-interval prolongation • levofloxacin + acarbose: concurrent use may result in changes in blood glucose or increased risk of hypoglycemia or hyperglycemia • levofloxacin + aminophylline: concurrent use may result in theophylline toxicity • levofloxacin + amiodarone: concurrent use may result in an increased risk of cardiotoxicity • ornidazole + doxacurium: concurrent use may result in the increased therapeutic efficacy of doxacurium • ornidazole + metocurine iodide: concurrent use may result in the increased therapeutic efficacy of metocurine iodide • ornidazole + mivacurium: concurrent use may result in the increased therapeutic efficacy of mivacurium • ornidazole + succinylcholine: concurrent use may result in the increased therapeutic efficacy of succinylcholine.